QXW — Cryoablation Device For Local Treatment Of Low-Risk Breast Cancer Class II

FDA Device Classification

Classification Details

Product Code
QXW
Device Class
Class II
Regulation Number
878.4355
Submission Type
Review Panel
SU
Medical Specialty
General, Plastic Surgery
Implant
No

Definition

A cryoablation device for local treatment of low-risk breast cancer is a prescription device that uses cold temperatures to destroy a breast tumor and its surrounding tissue. The device is intended as a local treatment and may be used with adjuvant therapies (e.g., endocrine therapy, radiation therapy) to reduce the risk of local disease progression. The device is intended for use in patients with a well-defined solid tumor (e.g., invasive ductal carcinoma) and with low risk of recurrence and metastasis, as determined by clinical risk factors consistent with the indications for use. The device is not intended to treat breast cancers with high risk of local recurrence (e.g., lobular carcinoma), patients with aggressive forms of breast cancer (e.g., breast cancers with inflammatory features), or patients in whom targeted systemic therapy is indicated.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
DEN220077icecure medicalProSense™ SystemOctober 3, 2025